International ophthalmology · 2026
Increased risk of corneal transplant rejection following SARS-CoV-2 infection and vaccination.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Allen Natalie E, Niederer Rachael L, Gokul Akilesh, Zhang Jie, Casey Anna, Tippett Georgia, McGhee Charles N J
Аннотация
BACKGROUND: To determine the impact of COVID-19 infection and vaccination on risk of corneal transplant rejection.
METHODS: All corneal transplants performed in Auckland, New Zealand (NZ), between January 2010 and December 2022 were included. Demographic, clinical, and surgical characteristics were recorded, along with COVID-19 vaccination and infection history. Time to corneal transplant rejection was analysed using Weibull survival regression with clustered standard errors at the graft level to account for repeated events and time-varying covariates.
RESULTS: A total of 1183 corneal transplants were performed in 926 patients, with a median age of 52 years (IQR 32-70); 47.5% were female. The median follow-up was 11.7 years ± 3.8. Within 3 months following COVID-19 vaccination, 1.1% of corneal transplants were rejected; within the same period following COVID-19 infection, 2.3% of transplants rejected. Overall, 277 transplants (23.4%) experienced rejection. On multivariable analysis, COVID-19 vaccination within 3 months was associated with elevated rejection risk (HR 1.834, p = 0.012), while COVID-19 infection within 3 months carried the greatest risk (HR 3.533, p < 0.001). Corneal transplant rejection was associated with significantly worse visual acuity follow-up (rejection median 20/160, no rejection 20/70, p < 0.001).
CONCLUSIONS: COVID-19 vaccination and infection were independently associated with an increased likelihood of corneal transplant rejection, with infection conferring the greatest risk. These findings suggest that systemic immune activation induced by SARS-CoV-2 immunisation may disrupt the delicate balance of transplant immunity and tolerance. This is the first large cohort study demonstrating an independent association between recent COVID-19 infection, vaccination, and increased risk of corneal graft rejection.
METHODS: All corneal transplants performed in Auckland, New Zealand (NZ), between January 2010 and December 2022 were included. Demographic, clinical, and surgical characteristics were recorded, along with COVID-19 vaccination and infection history. Time to corneal transplant rejection was analysed using Weibull survival regression with clustered standard errors at the graft level to account for repeated events and time-varying covariates.
RESULTS: A total of 1183 corneal transplants were performed in 926 patients, with a median age of 52 years (IQR 32-70); 47.5% were female. The median follow-up was 11.7 years ± 3.8. Within 3 months following COVID-19 vaccination, 1.1% of corneal transplants were rejected; within the same period following COVID-19 infection, 2.3% of transplants rejected. Overall, 277 transplants (23.4%) experienced rejection. On multivariable analysis, COVID-19 vaccination within 3 months was associated with elevated rejection risk (HR 1.834, p = 0.012), while COVID-19 infection within 3 months carried the greatest risk (HR 3.533, p < 0.001). Corneal transplant rejection was associated with significantly worse visual acuity follow-up (rejection median 20/160, no rejection 20/70, p < 0.001).
CONCLUSIONS: COVID-19 vaccination and infection were independently associated with an increased likelihood of corneal transplant rejection, with infection conferring the greatest risk. These findings suggest that systemic immune activation induced by SARS-CoV-2 immunisation may disrupt the delicate balance of transplant immunity and tolerance. This is the first large cohort study demonstrating an independent association between recent COVID-19 infection, vaccination, and increased risk of corneal graft rejection.